Results 1 to 10 of about 20,809 (160)
Diagnosis and management ofPneumocystis jiroveciiinfection [PDF]
Expert Review of Anti-Infective Therapy, 2017 Introduction: Pneumocystis jirovecii is a ubiquitous fungus, which causes pneumonia in humans. Diagnosis was hampered by the inability to culture the organism, and based on microscopic examination of respiratory samples or clinical presentation.
P Lewis White, Matthijs Backx
exaly +4 more sources
Comparative Genomics Suggests Primary Homothallism of
mBio, 2015 Pneumocystis species are fungal parasites of mammal lungs showing host specificity. Pneumocystis jirovecii colonizes humans and causes severe pneumonia in immunosuppressed individuals.
João M. G. C. F. Almeida +4 more
doaj +3 more sources
Differential composition of the pulmonary microbiome in HIV-positive versus HIV-negative patients with Pneumocystis jirovecii. [PDF]
PLoS ONEPneumocystis jirovecii is frequently detected in HIV patients and individuals with compromised immune function. The clinical outcomes of these two groups differ significantly, yet the underlying reasons remain unclear, with limited studies addressing ...
Chang-Run Zhang +9 more
doaj +2 more sources
Axenic Long-Term Cultivation of Pneumocystis jirovecii
Journal of Fungi, 2023 Pneumocystis jirovecii, a fungus causing severe Pneumocystis pneumonia (PCP) in humans, has long been described as non-culturable. Only isolated short-term experiments with P.
Diana Riebold +9 more
doaj +1 more source
Avicenna Journal of Medicine, 2023 Pneumocystis jirovecii pneumonia is an opportunistic fungal infection that was mainly associated with pneumonia in patients with advanced human immunodeficiency virus (HIV) disease.
Atif Ibrahim +9 more
doaj +1 more source
CONVENTIONAL METHODS FOR THE DIAGNOSIS OF PNEUMOCYSTIS JIROVECII IN IMMUNOCOMPROMISED IRAQI PATIENTS
The Iraqi Journal of Medical Sciences, 2016 Background: Pneumocystis jirovecii is the causative agent of pneumocystis pneumonia, one of the most frequent and severe opportunistic infections in immunocompromised patients.
Isa S. Touhali +2 more
doaj +6 more sources
SAGE Open Medical Case Reports, 2023 R-CHOP chemotherapy has been established as the first-line standard treatment for elderly patients diagnosed with diffuse large B-cell lymphoma. However, an increased risk of Pneumocystis jirovecii pneumonia in diffuse large B-cell lymphoma patients ...
Yan Xu +4 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2022 BackgroundPneumocystis jirovecii can result in a serious pulmonary infection, Pneumocystis jirovecii pneumonia, in immunocompetent hosts. The diagnosis of Pneumocystis jirovecii pneumonia has long been a major clinical concern, and there are limitations ...
Yangqing Zhan +8 more
doaj +1 more source
Annals of Clinical Microbiology and Antimicrobials, 2021 Background Pneumocystis jirovecii and Aspergillus fumigatus, are opportunistic pathogenic fungus that has a major impact on mortality in patients with systemic lupus erythematosus.
Yili Chen +6 more
doaj +1 more source
Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries. [PDF]
, 2007 Co-trimoxazole (trimethoprim-sulfamethoxazole) is a widely available antibiotic that substantially reduces HIV-related morbidity and mortality in both adults and children.
Abdel-Haq +33 more
core +2 more sources